Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Accumulated Expenses (2016 - 2025)

Nephros has reported Other Accumulated Expenses over the past 14 years, most recently at $75000.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $75000.0 for Q4 2025, up 41.51% from a year ago — trailing twelve months through Dec 2025 was $75000.0 (up 41.51% YoY), and the annual figure for FY2025 was $75000.0, up 41.51%.
  • Other Accumulated Expenses for Q4 2025 was $75000.0 at Nephros, up from $53000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for NEPH hit a ceiling of $94000.0 in Q4 2021 and a floor of $26000.0 in Q4 2022.
  • Median Other Accumulated Expenses over the past 5 years was $75000.0 (2025), compared with a mean of $68400.0.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 72.34% in 2022 and later soared 261.54% in 2023.
  • Nephros' Other Accumulated Expenses stood at $94000.0 in 2021, then crashed by 72.34% to $26000.0 in 2022, then soared by 261.54% to $94000.0 in 2023, then tumbled by 43.62% to $53000.0 in 2024, then soared by 41.51% to $75000.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $75000.0 (Q4 2025), $53000.0 (Q4 2024), and $94000.0 (Q4 2023) per Business Quant data.